Oppenheimer Holdings Inc. (OPY)
After hours:
| Previous close | 46.40 |
| Open | 46.58 |
| Bid | 46.24 x 1100 |
| Ask | 46.60 x 1200 |
| Day's range | 45.94 - 47.40 |
| 52-week range | 32.82 - 47.41 |
| Volume | |
| Avg. volume | 34,225 |
| Market cap | 479.369M |
| Beta (5Y monthly) | 1.15 |
| PE ratio (TTM) | 12.41 |
| EPS (TTM) | 3.74 |
| Earnings date | 26 July 2024 - 30 July 2024 |
| Forward dividend & yield | 0.60 (1.29%) |
| Ex-dividend date | 09 May 2024 |
| 1y target est | N/A |
PR NewswireOppenheimer Hires Kunal Bhatia As Managing Director, Healthcare Investment Banking
Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today that Kunal Bhatia joined as a Managing Director in the firm's Healthcare Investment Banking Group. He will be based in New York and report to Michael Margolis, R.Ph, Oppenheimer's Co-Head of Healthcare and Head of Healthcare Life Sciences Investment Banking.
Simply Wall St.In spite of recent selling, insiders still control 44% of Oppenheimer Holdings Inc. (NYSE:OPY)
Key Insights Insiders appear to have a vested interest in Oppenheimer Holdings' growth, as seen by their sizeable...
PR NewswireOppenheimer Expands Its Global Investment Banking Capabilities with the Addition of Martin Chamberlin
Oppenheimer Europe (Oppenheimer) — a subsidiary of Oppenheimer Holdings, the leading investment bank and wealth manager (NYSE: OPY) — announced today a further expansion of its European investment banking footprint with the addition of Martin Chamberlin.
